Want to create an interactive transcript for this episode?
Podcast: Opto Sessions – Invest in the Next Big Idea
Episode: ARK Invest's Ali Urman - Gene Editing, CRISPResso, & a $1.1 Trillion Market By 2026
Description: Get Opto’s best content every day, by subscribing to our FREE Newsletter: www.cmcmarkets.com/en/opto/newsletterAli Urman is ARK Invest’s Genomics analyst, responsible for the company’s research on Gene editing, DNA sequencing, Stem cell technologies & Immunotherapy. Spearheaded by one of the most talked-about investors in modern history, Cathie Wood, ARK Invest’s flagship fund received $1.5bn inflows in the first half of 2022, even as a tech sell-off continues to hamper its top holdings.I last spoke to Ali in November 2021, discussing the basics of DNA sequencing, and its overall potentia...